Em­press Ther­a­peu­tics con­firms lay­offs; Nanobi­otix amends J&J deal terms

Plus, news about Pyx­is On­col­o­gy, Kiromic Bio­Phar­ma, TC Bio­Pharm, En­ter­o­Bi­otix, Liq­uidia, Com­pass Path­ways, Vin­cerx Phar­ma and Neur­i­zon:

Em­press Ther­a­peu­tics un­der­goes lay­offs: A spokesper­son for the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.